¼¼°èÀÇ µðÁöÅРȣÈí±â ½ÃÀå
Digital Respiratory Devices
»óǰÄÚµå : 1774769
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 462 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è µðÁöÅРȣÈí±â ½ÃÀåÀº 2030³â±îÁö 3,133¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 745¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â µðÁöÅРȣÈí±â ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 27.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 3,133¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½º¸¶Æ® ÈíÀԱ⣦³×ºæ¶óÀÌÀú´Â CAGR 29.8%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 2,217¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼¾¼­£¦¾Û ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 21.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ¾à 203¾ï ´Þ·¯, Áß±¹Àº CAGR 36.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ µðÁöÅРȣÈí±â ½ÃÀåÀº 2024³â¿¡ 203¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 791¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 36.0%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 21.5%¿Í 24.5%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 22.9%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è µðÁöÅРȣÈí±â ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

µðÁöÅРȣÈí±â°¡ ¸¸¼ºÁúȯ °ü¸®¸¦ °³¼±ÇÒ ¼ö ÀÖÀ»±î?

õ½Ä, ¸¸¼º Æó¼â¼º ¤¤ÆóÁúȯ(COPD), Æó¼¶À¯Áõ°ú °°Àº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡´Â µðÁöÅРȣÈí±âÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ȯÀÚ ¸ð´ÏÅ͸µ ¹× Ä¡·á ¼øÀÀµµ¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ±âÁ¸ ÈíÀÔ±â ¹× ÆóȰ·®°è´Â ÇöÀç µðÁöÅÐ ¼¾¼­, ºí·çÅõ½º ¿¬°á, Ŭ¶ó¿ìµå ±â¹Ý ºÐ¼®°ú ÅëÇÕµÇ¾î Æó ±â´É, Åõ¾à·®, Áõ»ó ÆÐÅÏÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇÒ ¼ö ÀÖÀ¸¸ç, AI ±â¹Ý º¹¾à ¼øÀÀµµ ÃßÀû ±â¼úÀ» ÅëÇÕÇÑ ½º¸¶Æ® ÈíÀÔ±â´Â ȯÀÚ ¹× ÀÇ·áÁø¿¡°Ô Åõ¾à ¼øÀÀµµ ÃßÀû ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ȯÀÚ¿Í ÀÇ·áÁø¿¡°Ô Åõ¾à ´©¶ôÀ» °æ°íÇÏ¿© ´õ ³ªÀº Áúº´ °ü¸®¸¦ º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ, ¿þ¾î·¯ºí È£Èí ¸ð´ÏÅÍ¿Í ¿ø°Ý ÆóȰ·® ÃøÁ¤ ¼Ö·ç¼ÇÀ» ÅëÇØ Æó Àü¹®ÀǴ ȯÀÚÀÇ Æó °Ç°­ »óŸ¦ ¿ø°ÝÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ¾î º´¿ø ¹æ¹®°ú ÀÀ±Þ½Ç ÀÔ¿øÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª µðÁöÅРȣÈí±â´Â ÆíÀǼº°ú Á¤È®¼ºÀ» Çâ»ó½ÃŰ´Â ¹Ý¸é, µ¥ÀÌÅÍ ¾ÈÀü¼º, ±â±â °¡°Ý, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°úÀÇ ÅëÇÕ¿¡ ´ëÇÑ ¿ì·Á´Â ¿©ÀüÈ÷ Áß¿äÇÑ °úÁ¦·Î ³²¾ÆÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àå¾Ö¹°¿¡µµ ºÒ±¸Çϰí, µðÁöÅРȣÈí±â ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â ƯÈ÷ ÀÇ·á ½Ã½ºÅÛÀÌ È¯ÀÚÀÇ ¿ø°Ý ¸ð´ÏÅ͸µ°ú °³ÀÎÈ­µÈ Ä¡·á Àü·«À» Á¡Á¡ ´õ ¿ì¼±½ÃÇÔ¿¡ µû¶ó Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

AI¿Í IoT´Â È£Èí±â Ä¡·áÀÇ ¹Ì·¡¸¦ ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

ÀΰøÁö´É(AI)°ú »ç¹°ÀÎÅͳÝ(IoT)Àº ¿¹Ãø ºÐ¼®, °³ÀÎÈ­µÈ Ä¡·á Ãßõ, ¿øÈ°ÇÑ ±â±â ¿¬°áÀ» ÅëÇØ µðÁöÅРȣÈí±â¸¦ Å©°Ô Çâ»ó½Ã۰í ÀÖÀ¸¸ç, AI ±â¹Ý ¾Ë°í¸®ÁòÀº È£Èí±â ÆÐÅÏÀ» ºÐ¼®ÇÏ¿© COPD¿Í °°Àº ÁúȯÀÇ ¾ÇÈ­ ¡Èĸ¦ Á¶±â¿¡ °¨ÁöÇÏ¿© Àû±ØÀûÀÎ °³ÀÔÀ» °¡´ÉÇÏ°Ô Çϰí ÀÔ¿ø À§ÇèÀ» °¨¼Ò½Ãŵ´Ï´Ù. IoT Áö¿ø ½º¸¶Æ® ÈíÀÔ±â¿Í ºÐ¹«±â´Â »ç¿ë µ¥ÀÌÅ͸¦ ÀÇ·áÁø¿¡°Ô ÀÚµ¿À¸·Î Àü¼ÛÇÏ¿© ȯÀÚÀÇ º¹¾à ¼øÀÀµµ ¹× 󹿾àÀÇ È¿°ú¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, È£Èí±â ÀåÄ¡¿¡ ÅëÇÕµÈ À½¼º ÀÎ½Ä µðÁöÅÐ ¾î½Ã½ºÅÏÆ®´Â ȯÀÚ ±³À°À» °­È­Çϰí, »ç¿ëÀÚ¿¡°Ô ÀûÀýÇÑ ÈíÀÔ ±â¼úÀ» °¡¸£Ä¡°í, ¾à¹° ¼øÀÀµµ¸¦ °³¼±Çϱâ À§ÇÑ ¾Ë¸²À» Á¦°øÇÕ´Ï´Ù. AI ±â¹Ý µðÁöÅРȣÈí±â ¼Ö·ç¼ÇÀÇ ¼º°ø ¿©ºÎ´Â ¿¹Ãø ¸ðµ¨ÀÇ Á¤È®¼º°ú ÇコÄɾî ÀÎÇÁ¶ó¿ÍÀÇ ¿øÈ°ÇÑ »óÈ£¿î¿ë¼º¿¡ ´Þ·Á ÀÖÀ¸¸ç, AI¿Í IoT ±â¼úÀÌ °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó µðÁöÅРȣÈí±â´Â ¿¹Ãø ÀÇ·á¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ¼öÇàÇÏ¿© Àü ¼¼°è ¸¸¼º È£Èí±â ÁúȯÀÇ ºÎ´ãÀ» ÁÙÀÏ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ¸¸¼º È£Èí±â ÁúȯÀÇ ºÎ´ãÀ» ÁÙÀÏ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

µðÁöÅРȣÈí±â°¡ ¼Ò¾Æ ¹× ³ëÀÎ ÀǷḦ °³¼±ÇÒ ¼ö ÀÖÀ»±î?

¼Ò¾Æ ¹× ³ëÀÎÀÇ È£Èí±â Áúȯ °ü¸®´Â º¹¾à ¼øÀÀµµ, Áõ»ó ÀÎ½Ä ºÎÁ·, °£º´ÀÎÀÇ ÀÇÁ¸¼º µî ¿©·¯ °¡Áö ¾î·Á¿òÀÌ ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ¸ð´ÏÅ͸µ ±â´ÉÀ» °®Ãá µðÁöÅРȣÈí±â´Â ÀÌ·¯ÇÑ Ãë¾à °èÃþÀÇ °ü¸®¸¦ °³¼±ÇÏ´Â µ¥ ¸Å¿ì È¿°úÀûÀÓÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù. ¼Ò¾Æ Àü¿ë ½º¸¶Æ® ÈíÀÔ±â¿Í °ÔÀÓÈ­µÈ ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼Ǵ ¾ç¹æÇâ Æ©Å丮¾ó°ú º¸»ó ±â¹Ý Âü¿©¸¦ ÅëÇØ ¾î¸°À̵éÀÌ ÈíÀÔ±âÀÇ ¿Ã¹Ù¸¥ »ç¿ë¹ýÀ» ÀÌÇØÇϵµ·Ï µ½½À´Ï´Ù. ÇÑÆí, ÈíÀԱ⸦ ¿À¿ëÇϰųª Åõ¾à ½ºÄÉÁÙÀ» Àؾî¹ö¸± À§ÇèÀÌ ÀÖ´Â ³ëÀΠȯÀÚµéÀº ÀÚµ¿ ¾Ë¸², À½¼º ¾È³», ¿ø°Ý ÀÇ»ç »ó´ã µîÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖ½À´Ï´Ù. µðÁöÅРȣÈí±â ¼Ö·ç¼ÇÀº ¶ÇÇÑ °£º´Àο¡°Ô ½Ç½Ã°£ °Ç°­ µ¥ÀÌÅÍ¿¡ ´ëÇÑ ¾×¼¼½º¸¦ Á¦°øÇÏ¿© Áõ»óÀÌ ¾ÇÈ­µÉ °æ¿ì Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀü¿¡µµ ºÒ±¸Çϰí, ¼Ò¾Æ ¹× ³ëÀÎ ÀÇ·á ºÐ¾ß¿¡¼­ÀÇ µðÁöÅРȣÈí±â µµÀÔÀº ºñ¿ë Á¦¾à, »ç¿ë¼º¿¡ ´ëÇÑ ¿ì·Á, ³ë³âÃþÀÇ µðÁöÅÐ °ÝÂ÷ µîÀÇ À庮¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ±×·¯³ª ÇコÄÉ¾î ½Ã½ºÅÛÀÌ °³ÀÎ ¸ÂÃãÇü Ä¡·á¿Í ÀçÅà ġ·á¸¦ ÃßÁøÇÔ¿¡ µû¶ó µðÁöÅРȣÈí±â´Â ¸ðµç ¿¬·É´ëÀÇ ¸¸¼º È£Èí±â Áúȯ °ü¸®¿¡ ³Î¸® ¼ö¿ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

µðÁöÅРȣÈí±â ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

µðÁöÅРȣÈí±â ½ÃÀåÀÇ ¼ºÀåÀº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡, AI ¹× IoT ±â¹Ý ÇコÄÉ¾î ¼Ö·ç¼ÇÀÇ ¹ßÀü, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ ºÎ»ó µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. °¡Ä¡ ±â¹Ý ÀǷḦ ÇâÇÑ Àü ¼¼°èÀûÀÎ ¿òÁ÷ÀÓÀº ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô ȯÀÚ °á°ú¸¦ °³¼±ÇÏ°í º´¿ø ÀçÀÔ¿øÀ» ÁÙÀÏ ¼ö ÀÖ´Â µðÁöÅÐ µµ±¸¸¦ äÅÃÇϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ Ä¡·áÁ¦¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú ½º¸¶Æ® È£Èí±â ±â±â¿¡ ´ëÇÑ »óȯ Á¤Ã¥Àº ÀÌ·¯ÇÑ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. È£Èí±â ¸ð´ÏÅ͸µ°ú ¿ø°Ý ÀÇ·á Ç÷§ÆûÀÇ ÅëÇÕÀº Æó Àü¹®ÀÇ¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ôÀ̰í, Áø´Ü È¿À²À» °³¼±Çϸç, ÀÇ·á±â°üÀÇ ºÎ´ãÀ» °æ°¨½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àû±ØÀûÀΠȣÈí±â °Ç°­ °ü¸®¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö°í, ½ºÆÄÀÌ·Î¸ÞÆ®¸® ±â´ÉÀ» °®Ãá ¿þ¾î·¯ºí ±â±âÀÇ »ç¿ëÀÌ Áõ°¡Çϸ鼭 ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ³ôÀº ±â±â ºñ¿ë, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹®Á¦, º´¿ø IT ½Ã½ºÅÛ°úÀÇ ¿øÈ°ÇÑ ÅëÇÕÀÇ Çʿ伺 µîÀÇ °úÁ¦´Â ÀÖÁö¸¸, µðÁöÅРȣÈí±â ½ÃÀåÀº ¸¸¼ºÁúȯ °ü¸®¿Í ¿¹¹æÀÇÇÐ ¸ðµÎ¿¡ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á »ó´çÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(½º¸¶Æ® ÈíÀÔ±â&³×ºæ¶óÀÌÀú, ¼¾¼­£¦¾Û), ÀûÀÀÁõ(õ½Ä, COPD, ±âŸ Áúȯ), À¯Åë ä³Î(º´¿ø ¾à±¹, ¼Ò¸Å ¾à±¹, ¿Â¶óÀÎ ¾à±¹), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ÃÖÁ¾»ç¿ëÀÚ, ȨÄÉ¾î ½Ã¼³ ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Digital Respiratory Devices Market to Reach US$313.3 Billion by 2030

The global market for Digital Respiratory Devices estimated at US$74.5 Billion in the year 2024, is expected to reach US$313.3 Billion by 2030, growing at a CAGR of 27.0% over the analysis period 2024-2030. Smart Inhalers & Nebulizers, one of the segments analyzed in the report, is expected to record a 29.8% CAGR and reach US$221.7 Billion by the end of the analysis period. Growth in the Sensors & Apps segment is estimated at 21.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$20.3 Billion While China is Forecast to Grow at 36.0% CAGR

The Digital Respiratory Devices market in the U.S. is estimated at US$20.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$79.1 Billion by the year 2030 trailing a CAGR of 36.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.5% and 24.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 22.9% CAGR.

Global Digital Respiratory Devices Market - Key Trends & Drivers Summarized

Can Digital Respiratory Devices Improve Chronic Disease Management?

The rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis is driving the adoption of digital respiratory devices, revolutionizing patient monitoring and treatment adherence. Traditional inhalers and spirometers are now being integrated with digital sensors, Bluetooth connectivity, and cloud-based analytics, enabling real-time tracking of lung function, medication usage, and symptom patterns. Smart inhalers embedded with AI-powered adherence tracking technology alert patients and healthcare providers about missed doses, ensuring better disease management. Additionally, wearable respiratory monitors and remote spirometry solutions allow pulmonologists to assess patient lung health remotely, reducing hospital visits and emergency room admissions. However, while digital respiratory devices offer enhanced convenience and accuracy, concerns related to data security, device affordability, and integration with electronic health records (EHRs) remain key challenges. Despite these hurdles, the demand for digital respiratory solutions is expected to rise, particularly as healthcare systems increasingly prioritize remote patient monitoring and personalized treatment strategies.

How Is AI and IoT Shaping the Future of Respiratory Care?

Artificial intelligence (AI) and the Internet of Things (IoT) are significantly enhancing digital respiratory devices by enabling predictive analytics, personalized treatment recommendations, and seamless device connectivity. AI-driven algorithms analyze respiratory patterns to detect early signs of exacerbations in conditions like COPD, allowing for proactive intervention and reducing hospitalization risks. IoT-enabled smart inhalers and nebulizers automatically transmit usage data to healthcare providers, offering insights into patient adherence and effectiveness of prescribed medications. Additionally, voice-enabled digital assistants integrated into respiratory devices are enhancing patient education, guiding users on proper inhaler techniques, and offering reminders to improve medication compliance. However, the success of AI-driven digital respiratory solutions depends on the accuracy of predictive models and seamless interoperability with healthcare infrastructure. As AI and IoT technologies continue to evolve, digital respiratory devices are expected to play a crucial role in predictive healthcare, reducing the burden of chronic respiratory conditions worldwide.

Can Digital Respiratory Devices Improve Pediatric and Elderly Care?

Managing respiratory conditions in pediatric and elderly patients presents unique challenges, including difficulties in medication adherence, lack of symptom awareness, and caregiver dependence. Digital respiratory devices equipped with real-time monitoring capabilities are proving to be highly effective in improving care for these vulnerable populations. Pediatric-focused smart inhalers and gamified mobile applications are helping children understand proper inhaler usage through interactive tutorials and rewards-based engagement. Meanwhile, elderly patients, who are often at risk of misusing inhalers or forgetting medication schedules, benefit from automated reminders, voice-guided instructions, and remote physician consultations. Digital respiratory solutions also provide caregivers with access to real-time health data, enabling timely intervention in case of deteriorating symptoms. Despite these advancements, the adoption of digital respiratory devices in pediatric and geriatric care faces barriers such as cost constraints, usability concerns, and the digital divide among older populations. However, as healthcare systems push for personalized and home-based care, digital respiratory devices are expected to gain widespread acceptance in managing chronic respiratory conditions across all age groups.

What Is Driving the Growth of the Digital Respiratory Devices Market?

The growth in the digital respiratory devices market is driven by several factors, including the increasing prevalence of respiratory disorders, advancements in AI and IoT-enabled healthcare solutions, and the rise of remote patient monitoring systems. The global push toward value-based care is encouraging healthcare providers to adopt digital tools that enhance patient outcomes and reduce hospital readmissions. Regulatory approvals for digital therapeutics and reimbursement policies for smart respiratory devices are further boosting adoption. The integration of respiratory monitoring with telehealth platforms is expanding access to pulmonologists, improving diagnostic efficiency, and reducing the burden on healthcare facilities. Additionally, growing consumer awareness about proactive respiratory health management and the increasing use of wearables with spirometry capabilities are fueling market expansion. Despite challenges such as high device costs, data privacy concerns, and the need for seamless integration with hospital IT systems, the digital respiratory devices market is poised for substantial growth, offering innovative solutions for both chronic disease management and preventive care.

SCOPE OF STUDY:

The report analyzes the Digital Respiratory Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Smart Inhalers & Nebulizers, Sensors & Apps); Indication (Asthma, COPD, Other Diseases); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); End-Use (Hospitals End-Use, Homecare Settings End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â